These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 2655259

  • 21. [A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer].
    Miki T, Nonomura N, Kojima Y, Okuyama A, Nakano E, Kiyohara H, Fujioka H, Koide T, Wakatsuki A, Kuroda H, Sugao H, Seguti T, Takeyama M, Yamaguchi S.
    Hinyokika Kiyo; 1997 Dec; 43(12):907-12. PubMed ID: 9488944
    [Abstract] [Full Text] [Related]

  • 22. Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group.
    Kurth K, Schroeder FH, Debruyne F, Senge T, Pavone-Macaluso M, de Pauw M, ten Kate F, Sylvester R.
    Prog Clin Biol Res; 1989 Dec; 303():481-90. PubMed ID: 2675005
    [No Abstract] [Full Text] [Related]

  • 23. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
    Colombo R, Da Pozzo LF, Lev A, Salonia A, Rigatti P, Leib Z, Servadio C, Caldarera E, Pavone-Macaluso M.
    J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
    [Abstract] [Full Text] [Related]

  • 24. [Long-term intravesical treatment with adriamycin in chemoprevention of recurrence of transurethrally resected urinary bladder cancers].
    Flamm J, Grof F.
    Wien Med Wochenschr; 1987 Jul 15; 137(13):315-7. PubMed ID: 3114964
    [Abstract] [Full Text] [Related]

  • 25. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr 15; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 26. Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
    Kurth KH, Debruyne FJ, Senge T, Carpentier PJ, Riedl H, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1985 Apr 15; 185B():135-42. PubMed ID: 3898138
    [No Abstract] [Full Text] [Related]

  • 27. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec 15; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 28. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
    Serretta V, Pavone C, Ingargiola GB, Daricello G, Allegro R, Pavone-Macaluso M.
    Eur Urol; 2004 Jun 15; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
    [Abstract] [Full Text] [Related]

  • 29. Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of a randomized trial with epirubicin comparing short-term versus long-term maintenance treatment.
    Nomata K, Noguchi M, Kanetake H, Tsuda N, Hayashi M, Yamashita S, Sakuragi T, Kusaba Y, Shindo K, Nagasaki Clinical Research Group for Bladder Cancer.
    Cancer Chemother Pharmacol; 2002 Oct 15; 50(4):266-70. PubMed ID: 12357299
    [Abstract] [Full Text] [Related]

  • 30. Adjuvant intravesical mitoxantrone versus recombinant interferon-alpha after transurethral resection of superficial bladder cancer: a randomized prospective study.
    Papatsoris AG, Deliveliotis C, Giannopoulos A, Dimopoulos C.
    Urol Int; 2004 Oct 15; 72(4):284-91. PubMed ID: 15153724
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Long-term results of intravesical prevention of recurrence with mitomycin C and adriamycin in patients with superficial bladder cancer].
    Schwaibold H, Klingenberger HJ, Huland H.
    Urologe A; 1994 Nov 15; 33(6):479-83. PubMed ID: 7817443
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Deliveliotis C.
    J Urol; 2005 Jun 15; 173(6):1908-11. PubMed ID: 15879773
    [Abstract] [Full Text] [Related]

  • 36. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT, Soloway MS.
    Semin Urol Oncol; 1997 Aug 15; 15(3):147-53. PubMed ID: 9394909
    [Abstract] [Full Text] [Related]

  • 37. Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.
    Huncharek M, Kupelnick B.
    Am J Clin Oncol; 2003 Aug 15; 26(4):402-7. PubMed ID: 12902895
    [Abstract] [Full Text] [Related]

  • 38. [Results of a randomized, double blind prospective study of intravesical chemoprophylaxis with 2 drugs: adriamycin and mitomycin; and 2 ways of initiating the instillations: early and late. Effect on recurrence and progression].
    Iborra Juan I, Ricos Torrent JV, Monrós Lliso JL, Dumont Martínez R, Casanova Ramón-Borja J, Solsona Narbón E.
    Arch Esp Urol; 1992 Dec 15; 45(10):1001-7. PubMed ID: 1294028
    [Abstract] [Full Text] [Related]

  • 39. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M, Stotz N, Rassweiler J.
    J Endourol; 2007 Dec 15; 21(12):1533-41. PubMed ID: 18186695
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.